JP Patent

JP7641566B2 — 超微細化水難溶性薬物及び水溶性薬物を含む点眼剤並びにその製造方法及び使用方法

Assigned to Seed Co Ltd · Expires 2025-03-07 · 1y expired

What this patent protects

Patent listed against Temovate.

Drugs covered by this patent

Temovate (CLOBETASOL PROPIONATE) · Fougera Pharms

Patent Metadata

Patent number: JP7641566B2
Jurisdiction: JP
Classification: —
Expires: 2025-03-07
Drug substance claim: No
Drug product claim: No
Assignee: Seed Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.